��������

Amol Ketkar currently holds the position of Chief Development Officer (CDO) at Resolution Therapeutics, starting in June 2022. Prior to this, they worked at GSK, where they served in various roles including VP, Cell & Gene Therapy, Product Dev and Director of Biopharm. Dev. Amol started at GSK in 2001 and left in June 2022. Before joining GSK, they worked at Purdue Pharma L.P. as a Sr. Principal Scientist from 1996 to 2001. Their early career included a role as a Postdoctoral Fellow at The University of Iowa from 1994 to 1996.

Amol Ketkar holds a Doctor of Philosophy (Ph.D.) degree in Pharmaceutics from The Ohio State University.